Sousa, A C <br/><br/>
Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  01 2020 
 - 35-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2019.10.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>DNA Mutational Analysis--methods<br/>Decision Making<br/>ErbB Receptors--genetics<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Prognosis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Young Adult